Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5651_Библиотеки_им_академика_М_И_Перельмана.pdf
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Etminan, M., Gill, S. S., & Samii, A. (2005). Intake of vitamin E, vitamin C, and carotenoids and the
risk of Parkinson’s disease: A meta-analysis. Lancet Neurology, 4(6), 362–365. doi:10.1016/S14744422(05)70097-1 PMID:15907740
Farrer, M. J. (2006). Genetics of Parkinson disease: Paradigm shifts and future prospects. Nature Reviews.
Genetics, 7(4), 306–318. doi:10.1038/nrg1831 PMID:16543934
Fernando, I. S., Ryu, B., Ahn, G., Yeo, I. K., & Jeon, Y. J. (2020). Therapeutic potential of algal natural products against metabolic syndrome: A review of recent developments. Trends in Food Science &
Technology, 97, 286–299. doi:10.1016/j.tifs.2020.01.020
Ferreiro, E., Oliveira, C. R., & Pereira, C. M. (2008). The release of calcium from the endoplasmic
reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway.
Neurobiology of Disease, 30(3), 331–342. doi:10.1016/j.nbd.2008.02.003 PMID:18420416
Fitzpatrick, A. W., Debelouchina, G. T., Bayro, M. J., Clare, D. K., Caporini, M. A., Bajaj, V. S., & Dobson, C. M. (2013). Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proceedings
of the National Academy of Sciences of the United States of America, 110(14), 5468–5473. doi:10.1073/
pnas.1219476110 PMID:23513222
Fukunaga, K., & Miyamoto, E. (1998). Role of MAP kinase in neurons. Molecular Neurobiology, 16(1),
79–95. doi:10.1007/BF02740604 PMID:9554703
Gadad, B. S., Britton, G. B., & Rao, K. S. (2011). Targeting oligomers in neurodegenerative disorders:
Lessons from α-synuclein, tau, and amyloid-β peptide. Journal of Alzheimer’s Disease, 24(s2, Suppl 2),
223–232. doi:10.3233/JAD-2011-110182 PMID:21460436
Gangemi, S., Gofita, E., Costa, C., Teodoro, M., Briguglio, G., Nikitovic, D., Tzanakakis, G., Tsatsakis,
A. M., Wilks, M. F., Spandidos, D. A., & Fenga, C. (2016). Occupational and environmental exposure
to pesticides and cytokine pathways in chronic diseases [review]. International Journal of Molecular
Medicine, 38(4), 1012–1020. doi:10.3892/ijmm.2016.2728 PMID:27600395
Ganguly, G., Chakrabarti, S., Chatterjee, U., & Saso, L. (2017). Proteinopathy, oxidative stress and
mitochondrial dysfunction: Cross talk in Alzheimer’s disease and Parkinson’s disease. Drug Design,
Development and Therapy, 11, 797–810. doi:10.2147/DDDT.S130514 PMID:28352155
Gao, H. M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J. S. (2011). Neuroinflammation and
alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a
mouse model of Parkinson’s disease. Environmental Health Perspectives, 119(6), 807–814. doi:10.1289/
ehp.1003013 PMID:21245015
Gil-Mohapel, J., Brocardo, P. S., & Christie, B. R. (2014). The role of oxidative stress in Huntington’s
disease: Are antioxidants good therapeutic candidates? Current Drug Targets, 15(4), 454–468. doi:10.
2174/1389450115666140115113734 PMID:24428525
Giraldo, E., Lloret, A., Fuchsberger, T., & Vina, J. (2014). Abeta and tau toxicities in Alzheimer’s
are linked via oxidative stress induced p38 activation: Protective role of vitamin E. Redox Biology, 2,
873–877. doi:10.1016/j.redox.2014.03.002 PMID:25061569
198
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell, 140(6), 918–934. doi:10.1016/j.cell.2010.02.016 PMID:20303880
Goedert, M. (2015). Neurodegeneration. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α -synuclein. Science, 349(6248), 1255555. doi:10.1126cience.1255555
PMID:26250687
Hafycz, J. M., & Naidoo, N. N. (2019). Sleep, aging, and cellular health: Aged-related changes in sleep
and protein homeostasis converge in neurodegenerative diseases. Frontiers in Aging Neuroscience, 11,
140. doi:10.3389/fnagi.2019.00140 PMID:31244649
Hamer, M., & Chida, Y. (2009). Physical activity and risk of neurodegenerative disease: A systematic
review of prospective evidence. Psychological Medicine, 39(1), 3–11. doi:10.1017/S0033291708003681
PMID:18570697
Hamilton, A., & Holscher, C. (2012). The effect of ageing on neurogenesis and oxidative stress in the
APPswe/PS1deltaE9 mouse model of Alzheimer’s disease. Brain Research, 1449, 83–93. doi:10.1016/j.
brainres.2012.02.015 PMID:22418058
Hashim, S., & Hatamleh, A. (2021). Trigona Honey as a Potential Supplementary Therapy to Halt the
Progression of Post-Stroke Vascular Cognitive Impairment. International Medical Journal, 28(3), 335–338.
He, F., & Zuo, L. (2015). Redox roles of reactive oxygen species in cardiovascular diseases. International
Journal of Molecular Sciences, 16(11), 27770–27780. doi:10.3390/ijms161126059 PMID:26610475
Helferich, A. M., McLean, P. J., Weishaupt, J. H., & Danzer, K. M. (2016). Commentary: Alpha-synuclein
interacts with SOD1 and promotes its oligomerization. Journal of Neurology & Neuromedicine, 1(7),
28–30. doi:10.29245/2572.942X/2016/7.1065 PMID:27853754
Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature, 407(6805), 770–776.
doi:10.1038/35037710 PMID:11048727
Hensley, K., Mhatre, M., Mou, S., Pye, Q. N., Stewart, C., West, M., & Williamson, K. S. (2006). On the
relation of oxidative stress to neuroinflammation: Lessons learned from the G93A-SOD1 mouse model
of amyotrophic lateral sclerosis. Antioxidants & Redox Signaling, 8(11-12), 2075–2087. doi:10.1089/
ars.2006.8.2075 PMID:17034351
Hirsch, S., Labes, M., & Bähr, M. (2000). Changes in BDNF and neurotrophin receptor expression in
degenerating and regenerating rat retinal ganglion cells. Restorative Neurology and Neuroscience, 17(2-
3), 125–134. PMID:11490084
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V.
H. (2009). Systemic inflammation and disease progression in Alzheimer disease. Neurology, 73(10),
768–774. doi:10.1212/WNL.0b013e3181b6bb95 PMID:19738171
Hu, B., Yip, H. K., & So, K. F. (1998). Localization of p75 neurotrophin receptor in the retina of the adult
SD rat: An immunocytochemical study at light and electron microscopic levels. Glia, 24(2), 187–197.
doi:10.1002/(SICI)1098-1136(199810)24:2<187::AID-GLIA4>3.0.CO;2-1 PMID:9728765
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
199
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Huang, W. J., Zhang, X., & Chen, W. W. (2016). Role of oxidative stress in Alzheimer’s disease. Biomedical Reports, 4(5), 519–522. doi:10.3892/br.2016.630 PMID:27123241
Jarrett, J. T., & Lansbury, P. T. Jr. (1993). Seeding “one-dimensional crystallization” of amyloid: A
pathogenic mechanism in Alzheimer’s disease and scrapie? Cell, 73(6), 1055–1058. doi:10.1016/0092-
8674(93)90635-4 PMID:8513491
Kanninen, K., Malm, T. M., Jyrkkanen, H. K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto,
M., Ylä-Herttuala, S., Levonen, A.-L., & Koistinaho, J. (2008). Nuclear factor erythroid 2-related factor
2 protects against beta amyloid. Molecular and Cellular Neurosciences, 39(3), 302–313. doi:10.1016/j.
mcn.2008.07.010 PMID:18706502
Kao, T. K., Ou, Y. C., Raung, S. L., Lai, C. Y., Liao, S. L., & Chen, C. J. (2010). Inhibition of nitric
oxide production by quercetin in endotoxin/cytokine-stimulated microglia. Life Sciences, 86(9-10), 9–10,
315–321. doi:10.1016/j.lfs.2009.12.014 PMID:20060843
Katayama, S., & Nakamura, S. (2019). Emerging roles of bioactive peptides on brain health promotion.
International Journal of Food Science & Technology, 54(6), 1949–1955. doi:10.1111/ijfs.14076
Kermer, P., Digicaylioglu, M. H., Kaul, M., Zapata, J. M., Krajewska, M., Stenner-Liewen, F., Takayama,
S., Krajewski, S., Lipton, S. A., & Reed, J. C. (2003). BAG1 over-expression in the mouse brain protects
against stroke. Brain Pathology (Zurich, Switzerland), 13(4), 495–506. doi:10.1111/j.1750-3639.2003.
tb00480.x PMID:14655755
Kermer, P., Krajewska, M., Zapata, J. M., Takayama, S., Mai, J., Krajewski, S., & Reed, J. C. (2002).
Bag1 is a regulator and marker of neuronal differentiation. Cell Death and Differentiation, 9(4), 405–413.
doi:10.1038j.cdd.4400972 PMID:11965493
Knott, C., Stern, G., & Wilkin, G. P. (2000). Inflammatory regulators in Parkinson’s disease: iNOS,
lipocortin-1, and cyclooxygenases-1 and-2. Molecular and Cellular Neurosciences, 16(6), 724–739.
doi:10.1006/mcne.2000.0914 PMID:11124893
Kroemer, G., & Reed, J. C. (2000). Mitochondrial control of cell death. Nature Medicine, 6(5), 513–519.
doi:10.1038/74994 PMID:10802706
Kumar, A., & Ratan, R. R. (2016). Oxidative stress and Huntington’s disease: The good, the bad, and
the ugly. Journal of Huntington’s Disease, 5(3), 217–237. doi:10.3233/JHD-160205 PMID:27662334
Lau, F. C., Bielinski, D. F., & Joseph, J. A. (2007). Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. Journal of Neuroscience
Research, 85(5), 1010–1017. doi:10.1002/jnr.21205 PMID:17265471
Lee, E. J., Woo, M. S., Moon, P. G., Baek, M.-C., Choi, I.-Y., Kim, W.-K., Junn, E., & Kim, H.-S.
(2010). 𝛼-synuclein activates microglia byinducing theexpressions of matrixmetalloproteinases and the
subsequent activation of protease-activated receptor-1. Journal of Immunology (Baltimore, Md.: 1950),
185(1), 615–623. doi:10.4049/jimmunol.0903480 PMID:20511551
200
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Liepinsh, E., Ilag, L. L., Otting, G., & Ibáñez, C. F. (1997). NMR structure of the death domain of the
p75 neurotrophin receptor. The EMBO Journal, 16(16), 4999–5005. doi:10.1093/emboj/16.16.4999
PMID:9305641
Limbocker, R., Errico, S., Barbut, D., Knowles, T. P., Vendruscolo, M., Chiti, F., & Zasloff, M. (2022).
Squalamine and trodusquemine: Two natural products for neurodegenerative diseases, from physical chemistry to the clinic. Natural Product Reports, 39(4), 742–753. doi:10.1039/D1NP00042J PMID:34698757
Lin, M. T., & Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative
diseases. Nature, 443(7113), 787–795. doi:10.1038/nature05292 PMID:17051205
Liot, G., Valette, J., Pépin, J., Flament, J., & Brouillet, E. (2017). Energy defects in Huntington’s disease: Why “in vivo” evidence matters. Biochemical and Biophysical Research Communications, 483(4),
1084–1095. doi:10.1016/j.bbrc.2016.09.065 PMID:27639641
Liu, S. Q., Su, F., Fang, L. M., Xia, Q., & Zhang, X. (2010). Protective effect of apigenin on neurons
against oxygen‐glucose deprivation/reperfusion induced injury. The FASEB Journal, 24(S1), 604–6015.
doi:10.1096/fasebj.24.1_supplement.604.15
Ma, X., Cui, X., Li, J., Li, C., & Wang, Z. (2017). Peptides from sesame cake reduce oxidative stress and
amyloid-β-induced toxicity by upregulation of SKN-1 in a transgenic Caenorhabditis elegans model of
Alzheimer’s disease. Journal of Functional Foods, 39, 287–298. doi:10.1016/j.jff.2017.10.032
Ma, X., Li, J., Cui, X., Li, C., & Wang, Z. (2020). Dietary supplementation with peptides from sesame
cake alleviates Parkinson’s associated pathologies in Caenorhabditis elegans. Journal of Functional
Foods, 65, 103737. doi:10.1016/j.jff.2019.103737
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Remesy, C. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of
Clinical Nutrition, 81(1), 230–242. doi:10.1093/ajcn/81.1.230S PMID:15640486
Martin, L. J. (2001). Neuronal cell death in nervous system development, disease, and injury. Interna-
tional Journal of Molecular Medicine, 7, 455–478. doi:10.3892/ijmm.7.5.455 PMID:11295106
Matilla-Duenas, A., Ashizawa, T., Brice, A., Magri, S., McFarland, K. N., Pandolfo, M., Pulst, S. M.,
Riess, O., Rubinsztein, D. C., Schmidt, J., Schmidt, T., Scoles, D. R., Stevanin, G., Taroni, F., Underwood,
B. R., & Sánchez, I. (2014). Consensus paper: Pathological mechanisms underlying neurodegeneration
in spinocerebellar ataxias. Cerebellum (London, England), 13(2), 269–302. doi:10.100712311-0130539-y PMID:24307138
Mattson, M. P. (2000). Apoptosis in neurodegenerative disorders. Nature Reviews. Molecular Cell Biol-
ogy, 1(2), 120–129. doi:10.1038/35040009 PMID:11253364
Mattson, M. P., & Lindvall, O. (1997). Neurotrophic factor and cytokine signaling in the aging brain. In
M. P. Mattson & J. W. Geddes (Eds.), The Aging Brain (pp. 299–345). JAI Press. doi:10.1016/S15663124(08)60061-9
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
201
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Mazo, N. A., Echeverria, V., Cabezas, R., Avila-Rodriguez, M., Tarasov, V. V., Yarla, N. S., & Barreto, G.
E. (2017). Medicinal plants as protective strategies against Parkinson’s disease. Current Pharmaceutical
Design, 23(28), 4180–4188. doi:10.2174/1381612823666170316142803 PMID:28302024
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta,
D. A., & Di Monte, D. A. (2002). Environmental risk factors and Parkinson’s disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiology of Disease, 10(2),
119–127. doi:10.1006/nbdi.2002.0507 PMID:12127150
Meisl, G., Rajah, L., Cohen, S. A. I., Pfammatter, M., Šarić, A., Hellstrand, E., Buell, A. K., Aguzzi,
A., Linse, S., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2017). Scaling behaviour and ratedetermining steps in filamentous self-assembly. Chemical Science (Cambridge), 8(10), 7087–7097.
doi:10.1039/C7SC01965C PMID:29147538
Mi, K., & Johnson, G. V. (2006). The role of tau phosphorylation in the pathogenesis of Alzheimer’s
disease. Current Alzheimer Research, 3(5), 449–463. doi:10.2174/156720506779025279 PMID:17168644
Mijanur Rahman, M., Gan, S. H., & Khalil, M. (2014). Neurological effects of honey: Current and future prospects. Evidence-Based Complementary and Alternative Medicine, 2014, 2014. doi:10.1155/2014/958721
PMID:24876885
Miller, E., Morel, A., Saso, L., & Saluk, J. (2014). Isoprostanes and neuroprostanes as biomarkers of
oxidative stress in neurodegenerative diseases. Oxidative Medicine and Cellular Longevity. Article ID,
572491, 1–10.
Mochel, F., & Haller, R. G. (2011). Energy deficit in Huntington disease: Why it matters. The Journal
of Clinical Investigation, 121(2), 493–499. doi:10.1172/JCI45691 PMID:21285522
Mogi, M., Harada, M., Kondo, J., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994). Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated
in the brain from parkinsonian patients. Neuroscience Letters, 180(2), 147–150. doi:10.1016/03043940(94)90508-8 PMID:7700568
Mogi, M., Harada, M., Kondo, T., Narabayashi, H., Riederer, P., & Nagatsu, T. (1995). Transforming
growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson’s
disease. Neuroscience Letters, 193(2), 129–132. doi:10.1016/0304-3940(95)11686-Q PMID:7478158
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994). Tumor necrosis
factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian
patients. Neuroscience Letters, 165(1-2), 208–210. doi:10.1016/0304-3940(94)90746-3 PMID:8015728
Mohd Sairazi, N. S., Sirajudeen, K. N., Muzaimi, M., Mummedy, S., Asari, M. A., & Sulaiman, S. A.
(2018). Tualang honey reduced neuroinflammation and caspase-3 activity in rat brain after kainic acidinduced status epilepticus. Evidence-Based Complementary and Alternative Medicine, 2018, 2018.
doi:10.1155/2018/7287820 PMID:30108663
Moore, K. S., Wehrli, S., Roder, H., Rogers, M., Forrest, J. N. Jr, McCrimmon, D., & Zasloff, M. (1993).
Squalamine: An aminosterol antibiotic from the shark. Proceedings of the National Academy of Sciences
of the United States of America, 90(4), 1354–1358. doi:10.1073/pnas.90.4.1354 PMID:8433993
202
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Moreira, P. I., Zhu, X., Wang, X., Lee, H., Nunomura, A., Petersen, R. B., Perry, G., & Smith, M. A.
(2010). Mitochondria: A therapeutic target in neurodegeneration. Biochimica et Biophysica Acta, 1802(1),
212–220. doi:10.1016/j.bbadis.2009.10.007 PMID:19853657
Murphy, M. P., & Iii, H. L. (2010). AD and beta amyloid peptide. Journal of Alzheimer’s Disease, 19,
1–17. doi:10.3233/JAD-2010-1221.Alzheimer
Najafian, L., & Babji, A. S. (2012). A review of fish-derived antioxidant and antimicrobial peptides: Their
production, assessment, and applications. Peptides, 33(1), 178–185. doi:10.1016/j.peptides.2011.11.013
PMID:22138166
Nakamura, T., & Lipton, S. A. (2010). Preventing Ca2+−mediated nitrosative stress in neurodegenerative diseases: Possible pharmacological strategies. Cell Calcium, 47(2), 190–197. doi:10.1016/j.
ceca.2009.12.009 PMID:20060165
Nakamura, T., & Lipton, S. A. (2011). Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell
Death and Differentiation, 18(9), 1478–1486. doi:10.1038/cdd.2011.65 PMID:21597461
Newman, D. J., & Cragg, G. M. (2016). Natural products as sources of new drugs from 1981 to 2014.
Journal of Natural Products, 79(3), 629–661. doi:10.1021/acs.jnatprod.5b01055 PMID:26852623
Ni, Y., Wang, Z., Ma, L., Yang, L., Wu, T., & Fu, Z. (2019). Pilose antler polypeptides ameliorate inflammation and oxidative stress, and improves gut microbiota in hypoxic-ischemic injured rats. Nutrition
Research (New York, N.Y.), 64, 93–108. doi:10.1016/j.nutres.2019.01.005 PMID:30802728
Nizzari, M., S. Thellung, & Corsaro, A. (2012). Neurodegeneration in Alzheimer disease: role of amyloid
precursor protein and presenilin 1 intracellular signaling. Journal of Toxicology.
Okubadejo, N. U., Ojo, O. O., & Oshinaike, O. O. (2010). Clinical profile of parkinsonism and Parkinson’s disease in Lagos, Southwestern Nigeria. BMC Neurology, 10(1), 1–6. doi:10.1186/1471-2377-10-1
PMID:20051133
Oladele, J. O., Adewale, O. O., Oyeleke, O. M., Oyewole, I. O., Salami, M. O., & Owoade, G. (2020b).
Annona muricata protects against cadmium mediated oxidative damage in brain and liver of rats. Acta
Facultatis Medicae Naissensis, 37(3), 252–260. doi:10.5937/afmnai2003252O
Oladele, J. O., Adewale, O. O., Oyewole, O. I., Oyeleke, O. M., Ilori, O. T., & Olayinka, O. E. (2020c).
Modulatory Effects of Vitamin C and E on Cypermethrin-Induced Cardiac and Hepatic Damage in
Female Wistar Rats. Advances in Clinical Toxicology, 5(1), 1–7. doi:10.23880/ACT-16000182
Oladele, J. O., Ajayi, E. I. O., Oyeleke, O. M., Oladele, O. T., Olowookere, B. D., Adeniyi, B. M., &
Oyewole, O. I. (2021c). Curative potentials of Nigerian medicinal plants in COVID-19 treatment: A
Mechanistic approach. Jordan Journal of Biological Sciences, 13, 681–700.
Oladele, J. O., Ajayi, E. I. O., Oyeleke, O. M., Oladele, O. T., Olowookere, B. D., Adeniyi, B. M.,
Oyewole, O. I., & Oladiji, A. T. (2020c). A systematic review on COVID-19 pandemic with special
emphasis on Curative potentials of medicinal plants. Heliyon, 6(9), 1–17. doi:10.1016/j.heliyon.2020.
e04897 PMID:32929412
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
203
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Oladele, J. O., Oladele, O. T. & Oyeleke, O. M. (2021g). Possible health benefits of polyphenols in neurological complications associated with COVID-19. Acta Facultatis Medicae Naissensis, 38, 294-309.
Oladele, J. O., Oladele, O. T., Oyeleke, O. M., & Oladiji, A. T. (2021b). Neurological Complications in
COVID-19: Implications on International Health Security and Possible Interventions of Phytochemicals.
Contemporary Developments and Perspectives in International Health Security, 2. Advance online
publication. doi:10.5772/intechopen.96039
Oladele, J. O., Oladiji, A. T., Oladele, O. T., & Oyeleke, O. M. (2021a). Reactive Oxygen Species in
Neurodegenerative Diseases: Implications in Pathogenesis and Treatment Strategies. IntechOpen.
doi:10.5772/intechopen.99976
Oladele, J. O., Olowookere, B. D., Bamigboye, M. O., Oyeleke, O. M., Alabi, K. E., Oladele, O. O.,
& Oyewole, I. O. (2021e). Chemical Profiling, Phytochemical Constituents and In vitro Antioxidant
Activities of Ethanol Leaf Extract of Talinum Triangulare. Current Research in Chemistry, 13, 26–34.
doi:10.3923/crc.2021.26.34
Oladele, J. O., Oyeleke, O. M., Oladele, O. T., & Oladiji, A. T. (2021f). Covid-19 treatment: Investigation on the phytochemical constituents of Vernonia amygdalina as potential Coronavirus-2 inhibitors.
Computational Toxicology (Amsterdam, Netherlands), 18, 100161. doi:10.1016/j.comtox.2021.100161
PMID:33619460
Oladele, J. O., Oyeleke, O. M., Oladele, O. T., & Olaniyan, M. D. (2020a). Neuroprotective mechanism
of Vernonia amygdalina in a rat model of neurodegenerative diseases. Toxicology Reports, 7, 1223–1232.
doi:10.1016/j.toxrep.2020.09.005 PMID:32995297
Oladele, J. O., Oyeleke, O. M., Olowookere, B. D., Babatope, O. D., Olaniyan, M. D., Akindolie, B.
O., & Oladele, O. T. (2021d). Bitter leaf (Vernonia amygdalina) modulates nitrobenzene-induced renal
damage in rats via suppression of oxido-inflammatory activities. Serbian Journal of Experimental and
Clinical Research, 22(4), 317–324. Advance online publication. doi:10.2478jecr-2020-0040
Oladele, J. O., Oyeleke, O. M., Oyewole, O. I., Adewale, O. O., & Gbolagbade, A. (2019b). Assessment
of the protective effects of vitamin C and E on Cypermethrin-induced nephrotoxicity and electrolyte
imbalance in wistar rats. J. Basic and Applied Res Biomed, 6(1), 1–6. doi:10.51152/jbarbiomed.v6i1.1
Oladele, J. O., Oyewole, O. I., Bello, O. K., & Oladele, O. T. (2017). Assessment of Protective Potentials
of Ficus Exasperata Leaf on Arsenate-Mediated Dyslipidemia and Oxidative Damage in Rat’s Brain.
Journal of Basic and Applied Research, 3(3), 77–82.
Oladele, J. O., Oyewole, O. I., Oyeleke, O. M., Adewale, O. O., & Adeloju, E. O. (2019). Annona muricata
Attenuates Cadmium-Induced Oxidative Stress and Renal Toxicity in Wistar Rats. Journal Bioscience
and Applied Research, 5(4), 543–550. doi:10.21608/jbaar.2019.115571
Oyefuga, O. H., Ajani, E. O., Salau, B. A., Agboola, F., & Adebawo, O. O. (2012). Honey consumption and its anti-ageing potency in white Wister albino rats. Scholar Academic Journal of Biological
Science, 1(2), 15–19.
Oyewole, O. I., Olabiyi, B. F., & Oladele, J. O. (2017). Antioxidative potential of Ricinus Communis leaf
extract on Cadmium-induced liver and brain toxicity in Rats. UNIOSUN Journal of Sciences, 2(2), 84–90.
204
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Panov, A. V., Gutekunst, C. A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002). Early mitochondrial calcium defects in Huntington’s disease are a direct effect of
polyglutamines. Nature Neuroscience, 5(8), 731–736. doi:10.1038/nn884 PMID:12089530
Patten, D. A., Germain, M., Kelly, M. A., & Slack, R. S. (2010). Reactive oxygen species: Stuck in the
middle of neurodegeneration. Journal of Alzheimer’s Disease, 20(s2), 357–367. doi:10.3233/JAD-2010-
100498 PMID:20421690
Paudel, P., Park, S. E., Seong, S. H., Jung, H. A., & Choi, J. S. (2020). Bromophenols from Symphyocladia latiuscula target human monoamine oxidase and dopaminergic receptors for the management of
neurodegenerative diseases. Journal of Agricultural and Food Chemistry, 68(8), 2426–2436. doi:10.1021/
acs.jafc.0c00007 PMID:32011134
Paudel, P., Seong, S. H., Jung, H. A., & Choi, J. S. (2019). Characterizing fucoxanthin as a selective
dopamine D3/D4 receptor agonist: Relevance to Parkinson’s disease. Chemico-Biological Interactions,
310, 108757. doi:10.1016/j.cbi.2019.108757 PMID:31323226
Paudel, P., Seong, S. H., Zhou, Y., Park, H. J., Jung, H. A., & Choi, J. S. (2019). Anti-Alzheimer’s disease
activity of bromophenols from a red alga, symphyocladia latiuscula (Harvey) Yamada. ACS Omega, 4(7),
12259–12270. doi:10.1021/acsomega.9b01557 PMID:31460342
Perfeito, R., Cunha-Oliveira, T., & Rego, A. C. (2012). Revisiting oxidative stress and mitochondrial
dysfunction in the pathogenesis of Parkinson disease–resemblance to the effect of amphetamine drugs of
abuse. Free Radical Biology & Medicine, 53(9), 1791–1806. doi:10.1016/j.freeradbiomed.2012.08.569
PMID:22967820
Perlikowska, R. (2021). Whether short peptides are good candidates for future neuroprotective therapeutics? Peptides, 140, 170528. doi:10.1016/j.peptides.2021.170528 PMID:33716091
Perni, M., Flagmeier, P., Limbocker, R., Cascella, R., Aprile, F. A., Galvagnion, C., Heller, G. T., Meisl,
G., Chen, S. W., Kumita, J. R., Challa, P. K., Kirkegaard, J. B., Cohen, S. I. A., Mannini, B., Barbut,
D., Nollen, E. A. A., Cecchi, C., Cremades, N., Knowles, T. P. J., ... Dobson, C. M. (2018). Multistep
inhibition of α-synuclein aggregation and toxicity in vitro and in vivo by trodusquemine. ACS Chemical
Biology, 13(8), 2308–2319. doi:10.1021/acschembio.8b00466 PMID:29953201
Perni, M., Galvagnion, C., Maltsev, A., Meisl, G., Müller, M. B., Challa, P. K., Kirkegaard, J. B., Flagmeier, P., Cohen, S. I., Cascella, R., Chen, S. W., Limbocker, R., Sormanni, P., Heller, G. T., Aprile,
F. A., Cremades, N., Cecchi, C., Chiti, F., Nollen, E. A. A., ... Dobson, C. M. (2017). A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity. Proceedings of the
National Academy of Sciences of the United States of America, 114(6), E1009–E1017. doi:10.1073/
pnas.1610586114 PMID:28096355
Polidori, M. C., Mecocci, P., Browne, S. E., Senin, U., & Beal, M. F. (1999). Oxidative damage to mitochondrial DNA in Huntington’s disease parietal cortex. Neuroscience Letters, 272(1), 53–56. doi:10.1016/
S0304-3940(99)00578-9 PMID:10507541
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
205
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Qin, H., Srinivasula, S. M., Wu, G., Fernandes-Alnemri, T., Alnemri, E. S., & Shi, Y. (1999). Structural basis of procaspase-9 recruitment by the apoptotic protease activating factor 1. Nature, 399(6736),
549–557. doi:10.1038/21124 PMID:10376594
Rambaran, R. N., & Serpell, L. C. (2008). Amyloid fibrils: Abnormal protein assembly. Prion, 2(3),
112–117. doi:10.4161/pri.2.3.7488 PMID:19158505
Ramezanpour, M., Murphy, J., Smith, J. L., Vreugde, S., & Psaltis, A. J. (2017). In vitro safety evaluation of human nasal epithelial cell monolayers exposed to carrageenan sinus wash. International Forum
of Allergy & Rhinology, 7(12), 1170–1177. doi:10.1002/alr.22021 PMID:29024522
Reed, J. C. (2000). Mechanisms of apoptosis. American Journal of Pathology, 157(5), 1415–1430.
doi:10.1016/S0002-9440(10)64779-7 PMID:11073801
Reed, J. C. (2002). Apoptosis-based therapies. Nature Reviews. Drug Discovery, 11(2), 111–121.
doi:10.1038/nrd726 PMID:12120092
Rego, A. C., & Oliveira, C. R. (2003). Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases. Neurochemical
Research, 28(10), 1563–1574. doi:10.1023/A:1025682611389 PMID:14570402
Rocha, E. M., De Miranda, B., & Sanders, L. H. (2018). Alpha-synuclein: Pathology, mitochondrial
dysfunction and neuroinflammation in Parkinson’s disease. Neurobiology of Disease, 109, 249–257.
doi:10.1016/j.nbd.2017.04.004 PMID:28400134
Rodriguez-Martin, N. M., Toscano, R., Villanueva, A., Pedroche, J., Millan, F., Montserrat-de la Paz,
S., & Millan-Linares, M. C. (2019). Neuroprotective protein hydrolysates from hemp (Cannabis sativa
L.) seeds. Food & Function, 10(10), 6732–6739. doi:10.1039/C9FO01904A PMID:31576391
Ross, C. A., & Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease. Nature Medi-
cine, 10(S7), S10–S17. doi:10.1038/nm1066 PMID:15272267
Ross, C. A., & Tabrizi, S. J. (2011). Huntington’s disease: From molecular pathogenesis to clinical treatment. Lancet Neurology, 10(1), 83–98. doi:10.1016/S1474-4422(10)70245-3 PMID:21163446
Roth, W., Kermer, P., Krajewska, M., Krajewski, S., & Reed, J. C. (2003). Bifunctional apoptosis regulator (BAR) protects neurons from diverse cell death pathways. Cell Death and Differentiation, 10(10),
1178–1187. doi:10.1038j.cdd.4401287 PMID:14502241
Roy, N., Mahadevan, M. S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R., Baird, S., BesnerJohnston, A., Lefebvre, C., & Kang, X. (1995). The gene for neuronal apoptosis inhibitory protein is
partially deleted in individuals with spinal muscular atrophy. Cell, 80(1), 167–178. doi:10.1016/00928674(95)90461-1 PMID:7813013
Salmi, C., Loncle, C., Vidal, N., Laget, M., Letourneux, Y., & Michel Brunel, J. (2008). Antimicrobial
activities of 3-amino-and polyaminosterol analogues of squalamine and trodusquemine. Journal of Enzyme
Inhibition and Medicinal Chemistry, 23(6), 860–865. doi:10.1080/14756360701809910 PMID:19005944
206
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
Ecacy of Phytochemicals and Natural Products in the Management/Treatment
Salvesen, G. S., & Dixit, V. M. (1999). Caspase activation: The induced-proximity model. Proceedings
of the National Academy of Sciences of the United States of America, 96(20), 10964–10967. doi:10.1073/
pnas.96.20.10964 PMID:10500109
Schmits, R., Cochlovius, B., Treitz, G., Regitz, E., Ketter, R., Preuss, K. D., Romeike, B. F., & Pfreundschuh, M. (2002). Analysis of the antibody repertoire of astrocytoma patients against antigens expressed
by gliomas. International Journal of Cancer, 98(1), 73–77. doi:10.1002/ijc.10170 PMID:11857388
Seabrook, T. J., Jiang, L. Y., Maier, M., & Lemere, C. A. (2006). Minocycline affects microglia activation, a beta deposition, and behaviour in APP-tg mice. Glia, 53(7), 776–782. doi:10.1002/glia.20338
PMID:16534778
Shelat, P. B., Chalimoniuk, M., Wang, J. H., Strosznajder, J. B., Lee, J. C., Sun, A. Y., Simonyi, A., &
Sun, G. Y. (2008). Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. Journal of Neurochemistry, 106(1), 45–55.
doi:10.1111/j.1471-4159.2008.05347.x PMID:18346200
Shimizu, A., Mitani, T., Tanaka, S., Nakamura, S., & Katayama, S. (2018). Soybean- Derived GlycineArginine dipeptide administration promotes neurotrophic factor expression in the mouse brain. Journal
of Agricultural and Food Chemistry, 66(30), 7935–7941. doi:10.1021/acs.jafc.8b01581 PMID:29985005
Sicari, D., Igbaria, A., & Chevet, E. (2019). Control of protein homeostasis in the early secretory pathway:
Current status and challenges. Cells, 8(11), 1347. doi:10.3390/cells8111347 PMID:31671908
Singhal, G., Jaehne, E. J., Corrigan, F., Toben, C., & Baune, B. T. (2014). Inflammasomes in neuroinflammation and changes in brain function: A focused review. Frontiers in Neuroscience, 8, 315. doi:10.3389/
fnins.2014.00315 PMID:25339862
Sorolla, M. A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008). Proteomic
and oxidative stress analysis in human brain samples of Huntington disease. Free Radical Biology &
Medicine, 45(5), 667–678. doi:10.1016/j.freeradbiomed.2008.05.014 PMID:18588971
Soto, C. (2003). Unfolding the role of protein misfolding in neurodegenerative diseases. Nature Reviews.
Neuroscience, 4(1), 49–60. doi:10.1038/nrn1007 PMID:12511861
Soto, C., Estrada, L., & Castilla, J. (2006). Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends in Biochemical Sciences, 31(3), 150–155. doi:10.1016/j.tibs.2006.01.002
PMID:16473510
Spencer, J. P., Vafeiadou, K., Williams, R. J., & Vauzour, D. (2012). Neuroinflammation: Modulation
by flavonoids and mechanisms of action. Molecular Aspects of Medicine, 33(1), 83–97. doi:10.1016/j.
mam.2011.10.016 PMID:22107709
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., & Spiegelman, B. M. (2006). Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.
Cell, 127(2), 397–408. doi:10.1016/j.cell.2006.09.024 PMID:17055439
EBSCOhost - printed on 2/13/2023 11:18 AM via . All use subject to https://www.ebsco.com/terms-of-use
207